Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems

Annals of the New York Academy of Sciences

Volumn 1197, Issue , 2010, Pages 85-93

  MacArio, Alberto J L ^a   Cappello, Francesco ^b   Zummo, Giovanni ^b   Conway De MacArio, Everly ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Chaperoning system; Chaperoning system interactions; Chaperonopathies; Chaperonopathies by mistake; Chaperonotherapy, Hsp60

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; PROTEASOME; UBIQUITIN;

AGING; CATARACT; CHAPERONOPATHY; CONFERENCE PAPER; HUMAN; IMMUNE SYSTEM; PROTEIN DEFECT; PROTEIN INTERACTION; PROTEIN STRUCTURE; RETINOPATHY; SENESCENCE;

EID: 77953228373     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05187.x     Document Type: Conference Paper

References (52)

1. Macario, A.J.L. 1995.Heat-shock proteins andmolecular chaperones: implications for pathogenesis, diagnostics, and therapeutics. Int. J. Clin. Lab. Res. 25: 59-70.
2. Macario, A.J.L. & E. Conway de Macario. 2004. The pathology of anti-stress mechanisms: a new frontier. Stress 7: 243-249.
3. Macario, A.J.L. & E. Conway de Macario. 2005. Sick chaperones, cellular stress and disease. N. Engl. J. Med. 353: 1489-1501.
4. Macario, A.J.L. & E. Conway de Macario. 2002. Sick chaperones and ageing: a perspective. Ageing Res. Rev. 1: 295-311.
5. Kampinga, H.H. et al. 2009. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14: 105-111.
6. Hara, K. et al. 2005. Sacsin-related autosomal recessive ataxia without prominent retinal myelinated fibers in Japan. Mov. Disord. 20: 380-382.
7. Takiyama, Y. 2007. Sacsinopathies: sacsin-related ataxia. Cerebellum 6: 353-359.
8. Yamamoto, Y. et al. 2006. Sacsin-related ataxia caused by the novel nonsense mutation Arg4325X. J. Neurol. 253: 1372-1373.
9. Parfitt, D.A. et al. 2009. The ataxia protein sacsin is a functional cochaperone that protects against polyglutamine expanded ataxin-1. Hum. Mol. Genet. 18: 1556-1565.
10. Turbpaiboon, C. & P.Wilairat. 2010. Alpha-hemoglobin stabilizing protein: molecular function and clinical correlation. Front. Biosci. 15: 1-11.
11. Macario, A.J.L. & E. Conway de Macario. 2007. Molecular chaperones: multiple functions, pathologies, and potential applications. Front. Biosci. 12: 2588-2600.
12. Macario, A.J.L.&E.Conway deMacario. 2009. The chaperoning system: physiology and pathology. Exp. Med. Rev. 2/3: 9-21.
13. Bhattacharyya, J. et al. 2007. Effect of a single AGE modification on the structure and chaperone activity of human B-crystallin. Biochemistry 46: 14682-14692.
14. Cappello, F. et al. 2009. Hsp60 and Hsp10 in ageing. In Heat Shock Proteins andWhole Body Physiology. A.A.A. Asea&B.K. Pedersen, Eds: 401-426. Springer.NewYork, NY.
15. Macario, A.J.L., T.M. Grippo & E. Conway de Macario. 2005. Genetic disorders involving molecular-chaperone genes: a perspective. Genet. Med. 7: 3-12.
16. Macario, A.J.L. & E. Conway deMacario. 2007. Chaperonopathies by defect, excess, or mistake. Ann. N.Y. Acad. Sci. 1113: 178-191.
17. Ozawa, K. et al. 2001. Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone. Cancer Res. 61: 4206-4213.
18. Cappello, F. et al. 2002. Expression of 60 kDa heat shock protein increases during carcinogenesis in the uterine exocervix. Pathobiology 70: 83-88.
19. Cappello, F. et al. 2003. 60 kDa chaperonin (hsp60) is over-expressed during colorectal carcinogenesis. Eur. J. Histochem. 47: 105-110.
20. Cappello, F. et al. 2003. Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res. 23: 1325-1331.
21. Cappello, F. et al. 2003. Ten kilodalton heat shock protein (HSP10) is overexpressed during carinogenesis of large bowel and uterine exocervix. Cancer Lett. 196: 35-41.
22. Cappello, F. et al. 2005. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer 5: 139.
23. Rohde, M. et al. 2005. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev. 19: 570-582.
24. Desmetz, C. et al. 2008. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. J. Proteome Res. 7: 3830-3837.
25. Pick, E. et al. 2007. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res. 67: 2932-2937.
26. Stojadinovic, A. et al. 2007. HYOU1/Orp150 expression in breast cancer. Med. Sci. Monit. 13: BR231- BR239.
27. Campanella, C. et al. 2009. A comparative analysis of the products of GRoEL-1 gene from Chlamydia trachomatis serovar D and the HSP60 var1 transcript from Homo sapiens suggests a possible autoimmune response. Int. J. Immunogenet. 36: 73-78.
28. Cappello, F. et al. 2009. Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog. 5: e1000552.
29. Cappello, F. et al. 2008. Hsp60: new locations, functions, and perspectives for cancer diagnosis and therapy. Cancer Biol. Ther. 7: 801-809.
30. Osterloh, A. et al. 2007. Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide. J. Biol. Chem. 282: 4669-4680.
31. Osterloh, A. et al. 2008. Hsp60-mediated T cell stimulation is independent of TLR4 and IL-12. Int. Immunol. 20: 433-443.
32. Ohashi,K. et al. 2000.Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 64: 558-561.
33. Osterloh, A. et al. 2009. Heat shock protein 60 (HSP60) stimulates neutrophil effector functions. J. Leukoc. Biol. 86: 423-434.
34. Bangen, J.M., F.U. Schade & S.B. Floh́e. 2007. Diverse regulatory activity of human heat shock proteins 60 and 70 on endotoxin-induced inflammation. Biochem. Biophys. Res. Commun. 359: 709-715.
35. Elias, D. et al. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65- kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088-3091.
36. Zanin-Zhorov, A. et al. 2006. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J. Clin. Invest. 116: 2022-2032.
37. Kamphuis, S. et al. 2005. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 366: 50-56.
38. Ramage, J.M. et al. 1999. T cell responses to heat-shock protein 60: differential responses by CD4+ T cell subsets according to their expression of CD45 isotypes. J. Immunol. 162: 704-710.
39. Zanin-Zhorov, A. et al. 2003. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J. 17: 1567-1569.
40. Huurman, V.A. et al. 2007. Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients. Diabetes Metab. Res. Rev. 23: 269-275.
41. Huurman, V.A. et al. 2008. Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin. Exp. Immunol. 152: 488-497.
42. De Kleer, I.M. et al. 2003. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum. 48: 2001-2010.
43. Gao, B.&M.F. Tsan. 2004. Induction of cytokines by heat shock proteins and endotoxin in murine macrophages. Biochem. Biophys. Res. Commun. 317: 1149-1154.
44. Tsan, M.F. & B. Gao. 2009. Heat shock proteins and immune system. J. Leukoc. Biol. 85: 905-910.
45. Ostan, R. et al. 2008. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 15: 224-240.
46. Kiss, H.J. et al. 2009. Ageing as a price of cooperation and complexity: self-organization of complex systems causes the gradual deterioration of constituent networks. Bioessays 31: 651-664.
47. Nardai, G., P. Csermely&C. Soti. 2002. Chaperone function and chaperone overload in the aged: a preliminary analysis. Exp. Gerontol. 37: 1257-1262.
48. Nardai, G. et al. 2006. Chaperone-related immune dysfunction: an emergent property of distorted chaperone networks. Trends Immunol. 27: 74-79.
49. Soti, C. & P. Csermely. 2007. Aging cellular networks: chaperones as major participants. Exp.Gerontol. 42: 113-119.
50. Larbi, A., T. F̈ul̈op & G. Pawelec. 2008. Immune receptor signaling, aging and autoimmunity. Adv. Exp. Med. Biol. 640: 312-324.
51. Panda, A. et al. 2009.Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 30: 325-333.
52. Macario, A.J.L. & E. Conway deMacario. 2007. Chaperonopathies and chaperonotherapy. FEBS Lett. 581: 3681-3688.